Cyclacel Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK…

Biotechnology
US, Berkeley Heights [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of CYCC's Analysis
CIK: 1130166 CUSIP: 23254L603 ISIN: US23254L8019 LEI: - UEI: -
Secondary Listings
CYCC has no secondary listings inside our databases.